Literature DB >> 11137520

Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study.

I L Simone1, C Tortorella, F Federico, M Liguori, V Lucivero, P Giannini, D Carrara, A Bellacosa, P Livrea.   

Abstract

The purpose of this study was to compare magnetic resonance imaging (MRI) features and proton MR spectroscopy (1H-MRS) patterns of multiple sclerosis (MS) plaques in order to define the metabolic substrate in different lesion subtypes. Combined MRI and single-voxel 1H-MRS investigation was performed in 54 MS patients (47 relapsing remitting (RR) and seven secondary progressive (SP)). Sixty-seven MS lesions were selected. Thirty-seven lesions were Gadolinium (Gd) enhancing (nine isointense and 28 hypointense on pre-contrast T(1)-weighted scans) and 30 Gd unenhancing (six isointense and 24 hypointense on pre- and post-contrast T(1)-weighted scans). Choline (Cho), creatine (Cr), N-acetyl aspartate (NAA) and lactate were evaluated in 1H spectra acquired from MS plaques and from normal white matter (NWM) of 22 neurological controls. MS lesions of RR patients were characterized by a significant increase of Cho/Cr and decrease of NAA/Cr and NAA/Cho ratios. No significant metabolite changes were found in lesions of SP patients. Gd enhancing plaques showed lactate signal with higher frequency (37.8%) than Gd unenhancing plaques (16.7%) (p=0.04). A significant increase of Cho/Cr was found in Gd enhancing lesions when compared to controls (p<0.01), and to Gd unenhancing lesions (p<0.05). In particular, there was evidence of a significant increase of Cho/Cr in pre-contrast T(1) hypointense Gd enhancing lesions (p<0.01 vs. controls). The Gd unenhancing lesions (p<0.01), in particular the T(1) hypointense group (p<0.05), showed a significant decrease of NAA/Cr only when compared to controls. These data confirm that in vivo MRS indicates key pathological features of MS plaques. The increased Cho/Cr ratio found in Gd-enhancing plaques, in particular in the T(1) hypointense lesions, may reflect increased membrane cell turnover. The T(1) hypointense Gd unenhancing plaques better reflect axonal damage, as suggested by the decrease of NAA/Cr. Nevertheless, the lack of statistical differences in NAA/Cr between plaque subgroups suggests that axonal impairment might occur even in the early stages.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11137520     DOI: 10.1016/s0022-510x(00)00464-0

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  13 in total

Review 1.  Magnetic resonance spectroscopy in the monitoring of multiple sclerosis.

Authors:  Ponnada A Narayana
Journal:  J Neuroimaging       Date:  2005       Impact factor: 2.486

2.  Proton MR spectroscopy of lesion evolution in multiple sclerosis: Steady-state metabolism and its relationship to conventional imaging.

Authors:  Ivan I Kirov; Shu Liu; Assaf Tal; William E Wu; Matthew S Davitz; James S Babb; Henry Rusinek; Joseph Herbert; Oded Gonen
Journal:  Hum Brain Mapp       Date:  2017-05-19       Impact factor: 5.038

3.  Evaluation of normal appearing white matter in multiple sclerosis: comparison of diffusion magnetic resonance, magnetization transfer imaging and multivoxel magnetic resonance spectroscopy findings with expanded disability status scale.

Authors:  Y Anik; A Demirci; H Efendi; S S D Bulut; I Celebi; S Komsuoglu
Journal:  Clin Neuroradiol       Date:  2011-08-17       Impact factor: 3.649

4.  Metabolite findings in tumefactive demyelinating lesions utilizing short echo time proton magnetic resonance spectroscopy.

Authors:  A Cianfoni; S Niku; S G Imbesi
Journal:  AJNR Am J Neuroradiol       Date:  2007-02       Impact factor: 3.825

5.  Proton MR spectroscopy of tumefactive demyelinating lesions.

Authors:  Amit M Saindane; Soonmee Cha; Meng Law; Xiaonan Xue; Edmond A Knopp; David Zagzag
Journal:  AJNR Am J Neuroradiol       Date:  2002-09       Impact factor: 3.825

6.  Metabolic profile of PML lesions in patients with and without IRIS: an observational study.

Authors:  Sarah Gheuens; Long Ngo; Xiaoen Wang; David C Alsop; Robert E Lenkinski; Igor J Koralnik
Journal:  Neurology       Date:  2012-08-22       Impact factor: 9.910

7.  Hyperpolarized 13C MR metabolic imaging can detect neuroinflammation in vivo in a multiple sclerosis murine model.

Authors:  Caroline Guglielmetti; Chloé Najac; Alessandro Didonna; Annemie Van der Linden; Sabrina M Ronen; Myriam M Chaumeil
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-31       Impact factor: 11.205

Review 8.  Axonal degeneration in multiple sclerosis: can we predict and prevent permanent disability?

Authors:  Jae Young Lee; Kasra Taghian; Steven Petratos
Journal:  Acta Neuropathol Commun       Date:  2014-08-27       Impact factor: 7.801

9.  Metabolic changes in normal appearing white matter in multiple sclerosis patients using multivoxel magnetic resonance spectroscopy imaging.

Authors:  Jubao Sun; Hao Song; Yong Yang; Kun Zhang; Xiuju Gao; XiaoPan Li; Li Ni; Pan Lin; Chen Niu
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

10.  Differential expression of glucose-metabolizing enzymes in multiple sclerosis lesions.

Authors:  Philip G Nijland; Remco J Molenaar; Susanne M A van der Pol; Paul van der Valk; Cornelis J F van Noorden; Helga E de Vries; Jack van Horssen
Journal:  Acta Neuropathol Commun       Date:  2015-12-04       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.